A year ago this week I blogged about a study in the British Journal of Psychiatry that showed the dramatically reduced life expectancy of people with severe mental illness, who on average live 15-20 years less than the rest of the population. Twelve months on and a new study published in the same journal paints an equally [read the full story…]
Scotland sees increase in prescribing rates for mental health drugs
The Scottish Government have published their annual summary of prescribing statistics for mental health drugs. The report shows increases in the prescribing rates for all groups of drugs over the last 12 months. The prescribing costs of some groups of drugs have also risen (ADHD, dementia, depression) although other groups have seen a decline (insomnia [read the full story…]
Guest blog: Antidepressants and the Long Shadow of Stigma
Following the media coverage of the NHS statistics published last week that reported a large rise in antidepressant prescribing, Martin Brunet (a GP from Surrey and author of the excellent Binscombe Doctor Blog) has written an opinion piece that explores the positive and negative aspects of this complex story: “Are GPs prescribing antidepressants too readily?” [read the full story…]
The cost of antidepressant prescribing has risen by nearly a quarter in the last year, according to new NHS figures
The largest annual rise in prescriptions was seen in antidepressants according to figures published this week by the NHS Information Centre. 46.7 million prescriptions for antidepressants were dispensed in 2011, a rise of 3.9 million on 2010. This equates to a rise of 9.1% in the 12 month period, which is similar to that seen [read the full story…]
New Dental Prescribing App launched
The Scottish Dental Clinical Effectiveness Programme (SDCEP) has launched an app for use on iPhone®, iPad® and iPod touch® based on the second edition of their Drug Prescribing for Dentistry guidance. The app aims to facilitate drug prescribing within primary care dental practice by providing mobile access to the latest dentally relevant information compiled from [read the full story…]
Psychiatric drugs make up a bigger proportion of all prescription costs than they did a decade ago
There continues to be a considerable amount of debate about the amount of psychiatric medication that is prescribed and how much it costs. Statistics from a number of countries have shown that many classes of drugs are being prescribed more and more, including antidepressants, antipsychotics and stimulants. Of course, as populations grow, people live longer [read the full story…]
When is it appropriate to prescribe antipsychotics to treat the behavioural and psychological symptoms of dementia?
This topic has been well publicised in recent years and for good reason. We know that there is a huge disparity between the number of people with dementia who are prescribed antipsychotics (180,000 in England each year) and the number who may derive some benefit from the treatment (36,000). We also know that dangerous side [read the full story…]
New DH atlas of variation includes prescriptions of anti-dementia drugs and admissions for child mental health disorders
The second issue of the NHS Atlas of Variation in Healthcare has been published by the Department of Health as part of the QIPP (Quality, Innovation, Productivity and Prevention) programme. The aim of the Atlas is to reduce unwarranted variation in healthcare, increase value for money and improve quality of care. The idea behind this [read the full story…]
NHS publishes hospital prescribing bulletin for 2010, which focuses on ADHD and psychoses
This bulletin from the NHS Information Centre reports on the use of medicines in hospitals and puts their use into context by comparing it with their use in primary care and with medicines prescribed in hospitals but dispensed in the community. The bulletin explores the use of medicines used in the management of Attention Deficit [read the full story…]
Better prescribing for schizophrenia requires guidelines, frequent academic activities and a relaxed working environment
People with schizophrenia are sometimes prescribed multiple antipsychotic drugs, even though clinical guidelines rarely recommend this course of action. This cross-sectional observational study from Denmark explored the reasons behind this prescribing practice in two treatment centres; one that had high rates of antipsychotic polypharmacy and the other that had low rates. The researchers sent a [read the full story…]